FRIEDMAN MICHAEL R. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
FRIEDMAN MICHAEL R. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Michael R. Friedman is a prominent executive in the biotechnology sector, currently serving as the Chief Executive Officer of Galera Therapeutics, Inc. He has extensive experience in the pharmaceutical and biotechnology industries, having held various leadership roles in both public and private companies. Friedman is known for his strategic vision and ability to drive innovation in drug development.
Role
Insider
Notability
70/100
Board memberships
Galera Therapeutics, Inc.
Awards & honors
Led Galera Therapeutics through significant funding rounds
Oversaw the development of innovative cancer therapies
Michael R. Friedman is a prominent executive in the biotechnology sector, currently serving as the Chief Executive Officer of Galera Therapeutics, Inc. He has extensive experience in the pharmaceutical and biotechnology industries, having held various leadership roles in both public and private companies. Friedman is known for his strategic vision and ability to drive innovatio…
Where can I see all of FRIEDMAN MICHAEL R.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
